Comparison of diagnostic performance of five molecular assays for detection of SARS-CoV-2

被引：7
|
作者：
Kanwar, Neena [1 ,2 ]
Banerjee, Dithi [1 ,2 ]
Sasidharan, Anjana [1 ]
Abdulhamid, Ayah [1 ]
Larson, Marissa [3 ]
Lee, Brian [2 ,4 ]
Selvarangan, Rangaraj [1 ,2 ,3 ]
Liesman, Rachael M. [3 ]
机构：
[1] Childrens Mercy, Dept Pathol & Lab Med, Kansas City, MO 64108 USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Univ Kansas Hlth Syst, Dept Pathol & Lab Med, Kansas City, KS 66160 USA
[4] Childrens Mercy, Div Hlth Serv & Outcomes Res, Kansas City, MO USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2021年 / 101卷 / 04期
关键词：
SARS-CoV-2; detection; Molecular assay comparison; COVID-19;
D O I：
10.1016/j.diagmicrobio.2021.115518
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We compared the performance of the Abbott Real Time SARS-CoV-2 assay (Abbott assay), AptimaTM SARSCoV-2 assay (Aptima assay), BGI Real-Time SARS-CoV-2 assay (BGI assay), Lyra (R) SARS-CoV-2 assay (Lyra assay), and DiaSorin SimplexaTM COVID assay for SARS-CoV-2 detection. Residual nasopharyngeal samples (n = 201) submitted for routine SARS-CoV-2 testing by Simplexa assay during June-July 2020 and January 2021 were salvaged. Aliquots were tested on other assays and compared against the CDC 201 9-nCoV Real-Time RT-PCR assay. Viral load in positive samples was determined by droplet digital PCR. Among 201 samples, 99 were positive and 102 were negative by the CDC assay. The Aptima and Abbott assays exhibited the highest positive percent agreement (PPA) at 98.9% while the BGI assay demonstrated the lowest PPA of 89.9% with 10 missed detections. Negative percent agreement for all 5 platforms was comparable, ranging from 96.1% to 100%. The performance of all five assays was comparable. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数：7
相关论文
共 50 条
  • [31] Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences
    Camila Salazar-Ardiles
    Leyla Asserella-Rebollo
    Carlos Cornejo
    Dayana Arias
    Manuel Vasquez-Muñoz
    Camilo Toledo
    David C. Andrade
    [J]. Molecular Biology Reports, 2023, 50 : 10367 - 10382
  • [32] Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2
    Dust, Kerry
    Hedley, Adam
    Nichol, Kim
    Stein, Derek
    Adam, Heather
    Karlowsky, James A.
    Bullard, Jared
    Van Caeseele, Paul
    Alexander, David C.
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2020, 285
  • [33] Comparison of Four SARS-CoV-2 Neutralization Assays
    Riepler, Lydia
    Roessler, Annika
    Falch, Albert
    Volland, Andre
    Borena, Wegene
    von Laer, Dorothee
    Kimpel, Janine
    [J]. VACCINES, 2021, 9 (01) : 1 - 14
  • [34] Portable and visual assays for the detection of SARS-CoV-2
    Zhang, Yufan
    Ding, Dan
    [J]. VIEW, 2022, 3 (01)
  • [35] Comparison of Test Performance of Two Rapid SARS-CoV-2 Viral Assays
    Abdulbaki, R.
    Sands, Z.
    Isaacson, N.
    Codoy, M.
    Mendoza, S.
    Keiser, J.
    Komissarova, E.
    Halie-Mariam, T.
    Meltzer, A.
    Tritsch, S.
    Mores, C.
    Kochar, O.
    Sepulveda, J.
    Sepulveda, A.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S32 - S32
  • [36] Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
    Ainhoa Gutiérrez-Cobos
    Sara Gómez de Frutos
    Diego Domingo García
    Eva Navarro Lara
    Ayla Yarci Carrión
    Leticia Fontán García-Rodrigo
    Arturo Manuel Fraile Torres
    Laura Cardeñoso Domingo
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 955 - 961
  • [37] Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies
    Gutierrez-Cobos, Ainhoa
    Gomez de Frutos, Sara
    Domingo Garcia, Diego
    Navarro Lara, Eva
    Yarci Carrion, Ayla
    Fontan Garcia-Rodrigo, Leticia
    Fraile Torres, Arturo Manuel
    Cardenoso Domingo, Laura
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (05) : 955 - 961
  • [38] Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination
    Fresco-Taboada, Alba
    Garcia-Duran, Marga
    Aira, Cristina
    Lopez, Lissett
    Sastre, Patricia
    van der Hoek, Lia
    van Gils, Marit J.
    Brouwer, Philip J. M.
    Sanders, Rogier W.
    Holzer, Barbara
    Zimpernikc, Irene
    Lopez-Collazo, Eduardo
    Munoz, Patricia
    Rueda, Paloma
    Vela, Carmen
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 102 (04)
  • [39] Rapid Serological Tests for SARS-CoV-2: Diagnostic Performance of 4 Commercial Assays
    de Almeida, Sergio M.
    Spalanzani, Regiane N.
    Nogueira, Meri B.
    Sanada, Beatriz
    Cavalli, Barbara M.
    Rotta, Indianara
    Takahashi, Gislene R. A.
    Pereira, Luciane A.
    Moreira, Francielli B.
    Dino, Carolina L. T.
    Graf, Maria E.
    de Almeida, Bernardo M. M.
    Domino, Natalia R.
    Genelhoud, Gustavo
    Bochnia-Bueno, Lucas
    Raboni, Sonia M.
    [J]. MEDICAL PRINCIPLES AND PRACTICE, 2021, 30 (04) : 385 - 394
  • [40] Interlaboratory comparison of SARS-CoV2 molecular detection assays in use by US veterinary diagnostic laboratories
    Deng, Kaiping
    Uhlig, Steffen
    Ip, Hon S.
    Lea Killian, Mary
    Goodman, Laura B.
    Nemser, Sarah
    Ulaszek, Jodie
    Pickens, Shannon
    Newkirk, Robert
    Kmet, Matthew
    Frost, Kirstin
    Hettwer, Karina
    Colson, Bertrand
    Nichani, Kapil
    Schlierf, Anja
    Tkachenko, Andriy
    Reddy, Ravinder
    Reimschuessel, Renate
    [J]. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2021, 33 (06) : 1039 - 1051
12345